In search of the causes of Parkinson's disease, seasons 1 to 4

European Journal of Epidemiology

Volumn 26, Issue 7, 2011, Pages 505-509

  Elbaz, Alexis ^a,b  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; MANEB; ORGANOCHLORINE DERIVATIVE; PARAQUAT; ROTENONE; ZIRAM;

CAUSAL ATTRIBUTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DOPAMINERGIC NERVE CELL; ENVIRONMENTAL EXPOSURE; EVIDENCE BASED MEDICINE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; NERVE CELL NECROSIS; NEUROPATHOLOGY; NEUROTOXICITY; NOTE; OCCUPATIONAL EXPOSURE; PARKINSON DISEASE; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SMOKING; TEA;

HERBICIDES; HUMANS; MPTP POISONING; PARKINSON DISEASE; PARKINSON DISEASE, SECONDARY;

EID: 79961011022     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-011-9587-0     Document Type: Note

References (35)

1. Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J. Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol. 2011. doi:10.1007/s10654-011-9581-6.
2. Wang A, Costello S, Cockburn M, Zhang Z, Bronstein J, Ritz B. Parkinson's disease risk from ambient exposure to pesticides. Eur J Epidemiol. 2011. doi:10.1007/s10654-011-9574-5.
3. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 1983;219:979-80.
4. Priyadarshi A, Khuder SA, Schaub EA, Shrivastava S. A meta-analysis of Parkinson's disease and exposure to pesticides. Neurotoxicology. 2000;21:435-40.
5. Priyadarshi A, Khuder SA, Schaub EA, Priyadarshi SS. Environmental risk factors and Parkinson's disease: a metaanalysis. Environ Res. 2001;86:122-7. (Pubitemid 32656305)
6. Brown TP, Rumsby PC, Capleton AC, Rushton L, Levy LS. Pesticides and Parkinson's disease-is there a link? Environ Health Perspect. 2006;114:156-64.
7. Hernan MA, Takkouche B, CaamanoIsorna F, GestalOtero JJ. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol. 2002;52:276-84. (Pubitemid 35001493)
8. Ritz B, Ascherio A, Checkoway H, Marder KS, Nelson LM, Rocca WA, et al. Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol. 2007;64:990-7. (Pubitemid 47047999)
9. Tanner CM, Goldman SM, Aston DA, Ottman R, Ellenberg J, Mayeux R, et al. Smoking and Parkinson's disease in twins. Neurology. 2002;58:581-8. (Pubitemid 34164940)
10. Wirdefeldt K, Gatz M, Pawitan Y, Pedersen NL. Risk and protective factors for Parkinson's disease: a study in Swedish twins. Ann Neurol. 2005;57:27-33. (Pubitemid 40053312)
11. Elbaz A, Bower JH, Peterson BJ, Maraganore D, McDonnell SK, Ahlskog JE, et al. Survival study of Parkinson disease in Olmsted County, Minnesota. Arch Neurol. 2003;60:91-6.
12. Chen H, Zhang SM, Schwarzschild MA, Hernan MA, Ascherio A. Survival of Parkinson's disease patients in a large prospective cohort of male health professionals. Mov Disord. 2006;21:1002-7. (Pubitemid 44184603)
13. Chen H, Huang X, Guo X, Mailman RB, Park Y, Kamel F, et al. Smoking duration, intensity, and risk of Parkinson disease. Neurology. 2010;74:878-84.
14. Ritz B, Rhodes SL. After half a century of research on smoking, PD, where do we go now? Neurology. 2010;74:870-1.
15. Mellick GD, Gartner CE, Silburn PA, Battistuta D. Passive smoking and Parkinson's disease. Neurology. 2006;67:179-80.
16. O'Reilly EJ, Chen H, Gardener H, Gao X, Schwarzschild MA, Ascherio A. Smoking and Parkinson's disease: using parental smoking as a proxy to explore causality. Am J Epidemiol. 2009;169:678-82.
17. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, et al. Inhibition of monoamine oxidase B in the brains of smokers. Nature. 1996;379:733-6. (Pubitemid 26061736)
18. Hong DP, Fink AL, Uversky VN. Smoking and Parkinson's disease: does nicotine affect alpha-synuclein fibrillation? Biochim Biophys Acta. 2009;1794:282-90.
19. Savica R, Rocca WA, Ahlskog JE. When does Parkinson disease start? Arch Neurol. 2010;67:798-801.
20. Tan LC, Koh WP, Yuan JM, Wang R, Au WL, Tan JH, et al. Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese Health Study. Am J Epidemiol. 2008;167:553-60. (Pubitemid 351323310)
21. Stacy M, Silver D, Mendis T, Sutton J, Mori A, Chaikin P, et al. A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease. Neurology. 2008;70:2233-40.
22. Williams A. MPTP parkinsonism. BMJ. 1984;289:1401-2. (Pubitemid 15210956)
23. Kamel F, Tanner C, Umbach D, Hoppin J, Alavanja M, Blair A, et al. Pesticide exposure and self-reported Parkinson's disease in the agricultural health study. Am J Epidemiol. 2007;165:364-74.
24. Elbaz A, Clavel J, Rathouz PJ, Moisan F, Galanaud JP, Delemotte B, et al. Professional exposure to pesticides and Parkinson's disease. Ann Neurol. 2009;66:494-504.
25. Dick FD, De PG, Ahmadi A, Scott NW, Prescott GJ, Bennett J, et al. Environmental risk factors for Parkinson's disease and Parkinsonism: the Geoparkinson study. Occup Environ Med. 2007;64:666-72. (Pubitemid 47488093)
26. Hatcher JM, Pennell KD, Miller GW. Parkinson's disease and pesticides: a toxicological perspective. Trends Pharmacol Sci. 2008;29:322-9.
27. Cory-Slechta DA, Thiruchelvam M, Barlow BK, Richfield EK. Developmental pesticide models of the Parkinson disease phenotype. Environ Health Perspect. 2005;113:1263-70. (Pubitemid 41387671)
28. Gatto NM, Rhodes SL, Manthripragada AD, Bronstein J, Cockburn M, Farrer M, et al. Alpha-Synuclein gene may interact with environmental factors in increasing risk of Parkinson's disease. Neuroepidemiology. 2010;35:191-5.
29. Manthripragada AD, Costello S, Cockburn MG, Bronstein JM, Ritz B. Paraoxonase 1, agricultural organophosphate exposure, and Parkinson disease. Epidemiology. 2010;21:87-94.
30. Dick FD, De PG, Ahmadi A, Osborne A, Scott NW, Prescott GJ, et al. Gene-environment interactions in Parkinsonism and Parkinson's disease: the Geoparkinson study. Occup Environ Med. 2007;64:673-80. (Pubitemid 47488094)
31. Dutheil F, Beaune P, Tzourio C, Loriot M-A, Elbaz A. Interaction between ABCB1 and professional exposure to organochlorine insecticides in Parkinson's disease. Arch Neurol. 2010;67:739-45.
32. Kiyohara C, Miyake Y, Koyanagi M, Fujimoto T, Shirasawa S, Tanaka K, et al. GST polymorphisms, interaction with smoking and pesticide use, and risk for Parkinson's disease in a Japanese population. Parkinsonism Relat Disord. 2010;16:447-52.
33. Elbaz A, Ross OA, Ioannidis JP, Soto-Ortolaza AI, Moisan F, Aasly J et al. Independent and joint effects of the MAPT and SNCA genes in Parkinson disease. Ann Neurol. 2011;69:778-92.
34. International Parkinson Disease Genomics Consortium. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet. 2011;377:641-9.
35. Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M et al. Rotenone, Paraquat and Parkinson's disease. Environ Health Perspect. 2011; doi:10.1289/ehp.1002839.